Clinical Decision Support: Rewiring diagnostics strategy and redefining market leadership

Published on September 3, 2026

Clinical Decision Support (CDS) is reshaping diagnostics strategy. As momentum builds, the question for manufacturers is how to invest with discipline, capture growth, and long-lasting value.

Key takeways

  • Clinical Decision Support (CDS) is quickly becoming a strategic priority for healthcare manufacturers, but successful investment is complex. 

  • Barriers mirror those seen in other digital health innovations, including integration challenges, unclear ROI, and stakeholder misalignment.

  • Manufacturers acting decisively on CDS stand to gain competitive advantage and reinforce long-term portfolio value.

    …

    Simon-Kucher insights_Smart moves in Clinical Decision Support investments

Continue reading on website
Other news

4th Annual commercial roundtable: World-class revenue operations & capabilities for the future of sales

September 1, 2026
We are coming off a tumultuous 2025 with tariffs, lower interest rates, moderate GDP growth, and strong equity performance.  Sales leaders are re-discovering pre-Covid investments with substantial success.  Artificial intelligence is making its way into more facets of the economy, driving growth in software, semiconductors, data center, energy, and other sectors. Some companies that lagged in 2024

Private label vs. brand: Who wins the shopper?

September 4, 2026
Private label has reached a tipping point. What started as a trade-down response to inflation has evolved into a lasting shift in consumer behavior. Our 2026 Global Shopper Study shows that branded products are no longer the default. They are being questioned, compared, and often rejected. For brands, this is more than competition. It’s a moment of truth.In our exclusive webinar, we uncover how sh